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abstract – Objective: Ependymomas are rare intracranial neuroepithelial tumors and the most common location 
is intramedullary. The aim was to analyze the characteristics of these tumors to determine the patients’ overall 
survival and the likelihood of recurrence.  Method: Data of clinical presentation, tumor location, duration of 
symptoms, degree of resection and complementary treatment of 34 patients with intracranial ependymoma 
and 31 with intramedullary ependymoma who underwent surgery in the last ten years were collected and 
correlated with the recurrence time and overall survival.  Results: There was statistically significant correlation 
between the degree of resection and intracranial tumor location, although it is not a hallmark of recurrence. 
Data analyses of intramedullary ependymoma did not show correlation with overall survival and likelihood 
of recurrence.  Conclusion: The location of the intracranial tumor is connected with the degree of resection; 
however it is not a predictive factor to overall survival. 
KEy worDS: brain tumor, intramedullary tumor, ependymoma.
ependimoma craniano e de medula espinhal: casuística da Faculdade de medicina da Universidade de são paulo
resumo – Objetivo: os ependimomas são tumores neuroepiteliais raros na localização intracraniana, porém um 
dos mais freqüentes na medula espinhal. os autores analisaram as características destes tumores para determinar 
a sobrevida e probabilidade de recidiva nos pacientes.  Método: Elementos da apresentação clínica, localização da 
lesão, duração de sintomatologia, grau de ressecção e tratamento complementar de 34 doentes com ependimoma 
intracraniano e 31 de medula espinhal operados nos últimos dez anos foram revisados e correlacionados com 
o período para a ocorrência da recidiva e a sobrevida.  Resultados: Houve correlação estatística apenas entre 
o grau da ressecção e a localização dos ependimomas intracranianos, embora, este não se tenha mostrado um 
marcador de recidiva. A avaliação dos dados clínicos dos pacientes com ependimoma medular não permitiu 
definir correlação com a sobrevida e sobre a probabilidade de recorrência.  Conclusão: A localização do tumor 
intracraniano está relacionada ao grau de ressecção, entretanto isso não foi um fator preditivo para a sobrevida. 
PAlAvrAS-cHAvE: tumor cerebral, tumor intramedular, ependimoma.
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Ependymomas are rare tumors of neuroectodermal 
origin. They may arise from the ependymal cells of filum 
terminale, or from the cells that cover the central canal 
of the spinal cord or ventricular surface, or from the cells 
of the adjacent white matter to the ventricular surface, 
and fetal residual ependymal cells which migrate from 
periventricular regions1,2. 
overall, they account for 6–9% of the intracranial 
tumors. They are the third most common tumor in the 
youngest age group, representing 30% of the intracranial 
primary neoplasms in individuals with less than three years 
of age3. Intramedullary spinal ependymomas are more 
common in individuals with 15 to 40 years of the age, rep-
resenting about 30% of the ependymomas of the central 
nervous system and 60% of the intramedullary tumors4. 
clinical presentation is non-specific and depends on 
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the patient’s age and the tumor location. Duration of the 
symptoms until diagnosis varies from one month to three 
years, generally being from three to six months5. Diagnosis 
is complemented by computerized tomography or mag-
netic resonance scanning of the central nervous system 
with image samples varying because of calcification pres-
ence, cystic or solid areas, microscopical areas of hemor-
rhages, necrosis, etc. 
The aim of this study is to define the characteristics of 
the population of patients who had undergone surgery in 
last the ten years and to correlate them with overall sur-
vival and the probability of recurrence to determine hall-
marks of prognosis.
metHod
Thirty-four patients with intracranial ependymoma and 31 
with intramedullary spinal cord or cauda equine ependymoma 
that were consecutively submitted to surgery in the Hospital das 
clinicas at Faculdade de Medicina, Universidade de São Paulo 
from 1997 to 2007 have been assessed. 
Table 1. Patients’ gender, age, clinical presentation, time between symptoms onset and surgery, tumor location, degree of resection, 
complementary treatment, time from surgery to recurrence, tumor location at recurrence and death status in patients with intracranial 
ependymoma at age between 0–15 years. 
Patient 
and
gender
Age
(years)
clinical 
presentation
Time between 
symptoms onset 
and surgery 
(months)
Tumor 
location
Degree of 
resection
complementary 
treatment recurrence
Time from 
surgery to 
recurrence 
(months)
Tumor location 
at recurrence Dead
Between 0–15 years
1,M 15 high IcP 47 infratentorialzz subtotal 
(invaded the 
brainstem)
yes (rT + QT) no –  – no
2, F 4 focal + 
high IcP
4 infratentorial partial 
(stopped 
because of 
bleeding)
no no –  – yes
3, M 1.5 focal + 
high cP
6 infratentorial total no yes 1 infratentorial no
4, F 1.5 focal 2 infratentorial partial no no –  – no
5, F 3 high IcP 1 infratentorial total yes (rT) yes 9 conus 
medullaris
no
6, M 2 focal 8 infratentorial partial 
(invaded the 
brainstem)
yes (QT) no –  – no
7, F 9 high IcP 4 infratentorial partial 
(invaded the 
brainstem 
and cranial 
nerves)
yes (rT before 
surgery)
no –  – no
8, F 13 high IcP 5 supratentorial total no no –  – no
9, M 6.5 high IcP 3 supratentorial partial yes (QT + rT) yes 8 supratentorial no
10, M 9 seizure + 
focal + 
high IcP
2 supratentorial total yes 
(craniospinal rT)
yes 90 same 
location
no
11, M 5 focal + 
high IcP
3 supratentorial total no yes 18 same 
location
no
12, F 3.5 focal + 
high IcP
2 supratentorial partial yes (QT) no –  – no
13, M 2.5 focal 4 supratentorial total no no – – no
14, M 3.5 focal + 
high IcP
10 supratentorial total no yes 31 infratentorial no
15, M 6 focal 3 supratentorial total yes (QT + rT) yes 17 supratentorial yes
16, F 7 IcP 1 supratentorial total yes (rT before 
2nd surgery)
yes 6 supratentorial no
17, F 12 seizure + 
focal + 
high IcP
4 supratentorial total yes (rT) no – – no
18, F 0.5 seizure + 
high IcP
1 supratentorial total no no –  – yes
M: male; F: female; IcP: increased intracranial pressure; focal: motor deficits (paresis); seizure: partial seizure or generalized seizure; rT: radiation therapy; QT: 
chemotherapy; rFTP: right fronto temporoparietal.
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Table 1 (continuation). Patients’ gender, age, clinical presentation, time between symptoms onset and surgery, tumor location, degree of 
resection, complementary treatment, time from surgery to recurrence, tumor location at recurrence and death status in patients with 
intracranial ependymoma at age over 15 years. 
Patient 
and 
gender
Age
(years)
clinical 
presentation
Time between 
symptoms onset 
and surgery 
(months)
Tumor 
location
Degree of 
resection
complementary 
treatment recurrence
Time from 
surgery to 
recurrence 
(months)
Tumor location 
at recurrence Dead
19, M 46 visual + 
high IcP
2 infratentorial total no no –  – no
20, F 51 high IcP 1 infratentorial total no no –  – no
21, M 23 visual + 
high IcP
16 infratentorial subtotal 
(invade the 
brainstem)
yes (rT) yes 50 infratentorial no
22, F 25 visual + 
high IcP
4 infratentorial partial 
(invade the 
brainstem)
yes 
(craniospinal rT)
yes 1 same location yes
23, F 34 visual + focal 
+ high IcP
6 infratentorial total yes (rT) no –  – no
24, F 41 high IcP 3 infratentorial subtotal yes (QT) no –  –
25, M 28 visual + 
high IcP
1 infratentorial subtotal 
(invade 
the floor 
of fourth 
ventricle)
no no –  – yes
26, M 45 high IcP + 
nerves
24 infratentorial partial 
(invade the 
brainstem)
yes (rT) no –  – yes
27, F 27 high IcP + 
cerebellar
1 infratentorial subtotal 
(invade the 
brainstem)
no no –  – yes
28, F 73 high IcP 5 supratentorial total yes (QT + rT) yes 1 r FTP no
29, F 18 seizure + 
high IcP
8 supratentorial total no no –  – no
30, F 24 seizure + 
high IcP
36 supratentorial total no no –  – no
31, F 22 seizure 
+ focal + 
high IcP
8 supratentorial total yes (rT) yes 28 same 
location and 
supratentorial 
no
32, M 42 Focal 2 supratentorial total yes (rT) no –  – no
33, F 17 High IcP 6 supratentorial subtotal yes (rT) no –  – no
34, M 42 High IcP 43 supratentorial total no no –  – no
M: male; F: female; IcP: increased intracranial pressure; focal: motor deficits (paresis); seizure: partial seizure or generalized seizure; rT: radiation therapy; QT: 
chemotherapy; rFTP: right fronto temporoparietal.
Data of the clinical presentation, tumor location, duration 
of the symptoms until the surgery, degree of resection, com-
plementary treatment were collected and are presented in Ta-
bles 1 and 2. Data of intracranial ependymomas in children and 
adults and spinal cord ependymomas are presented in separate 
tables and were correlated with the location of the tumor and 
the recurrence time and overall survival. SPSS v.15 was used for 
the statistical analyses of intracranial and intramedullary sub-
groups to define the possible prognostic factors.
This project is supported by FAPESP (number 04/12133-6) 
and cAPES (number 691/05) and their ethics commission.
resUlts
The mean age of the patients with intracranial 
ependymoma was 19 years (6 months to 73 years) (Fig 1A). 
Nineteen patients were female (55.8%) and the location 
was infratentorial in 47.1% of them. The most common 
symptoms were only increased intracranial pressure (IcP) 
(28.1%) or IcP elevation associated with focal neurologi-
cal deficits (25%). Focal deficit was the only symptom in 
15.6% of these patients. visual complaints associated with 
elevated IcP symptoms were present in 12.5% of cases. 
Seizures occurred only in supratentorial tumors; in 9.4% 
of cases it was associated only with increased IcP and in 
9.4% of cases it was also associated with focal deficits. 
The mean time between symptoms onset and the sur-
gery was 8 months (1 month to 4 years). The correlation 
between location and the symptom with mean time be-
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Table 2. Patients’ gender, age, clinical presentation, time between symptoms onset and surgery, tumor location, degree of resection, 
complementary treatment, time from surgery to recurrence, tumor location at recurrence and death status in patients with intramedullary 
and conus medullaris ependymoma. 
Patients
and
gender
Age 
(years)
clinical 
presentation
Time between 
symptoms onset 
and surgery 
(months)
Tumor 
location
Degree of 
resection
complementary 
treatment recurrence
Time from 
surgery to 
recurrence 
(months)
Tumor location 
at recurrence Dead
1, M 22 pain 104 c3–T4 total no no –  – no
2, M 43 pain + deficit 34 c2–c5 total no no –  – no
3, F 39 deficit 44 c4–c5 partial no no –  – yes
4, F 28 deficit 22 c4–T4 total no no –  – no
5, M 31 dysesthesias 
+ deficit
124 c2–c7 total no no –  – no
6, M 30 dysesthesias 
+ deficit
11 c2–T1 total no no –  – no
7, F 22 pain + deficit 65 T6–T8 total no yes 40 same location no
8, F 50 dysesthesias 
+ deficit
12 T10–T11 total no no –  – no
9, M 18 dysesthesias 
+ deficit
16 T12–l5 total no no –  – no
10, M 19 pain 17 c1–c4 total no no –  – no
11, F 33 pain + deficit 123 c3–T3 total no no –  – no
12, M 32 pain + deficit 6 T11–l4 partial no no –  – no
13, F 27 dysesthesias 
+ deficit
39 T1–T3 total no no –  – no
14, F 23 pain + deficit 8 c5–T9 partial no yes 1 posterior 
fossa (partial 
resection)
no
15, M 42 pain + 
dysesthesias
52 T12 + conus 
medullaris
total no no –  – no
16, M 21 pain 36 filum 
terminale
partial no no –  – no
17, M 22 deficit 43 T9–T11 total no no –  – no
18, F 9 pain + deficit 10 T10–l3 total yes (rT) yes 3 same location  
e craniospinal 
seeding
yes
19, F 35 dysesthesias 
+ deficit
28 c4–T2 total no no –  – no
20, F 60 pain + deficit 10 T9–T11 subtotal no yes 48 same location no
21, F 9 deficit 9 c1–c6 total yes (QT + rT) yes 29 cPA and 
supratentorial; 
craniospinal 
seeding
no
22, M 63 dysesthesias 
+ deficit
8 T5–T10 subtotal no no –  – no
23, F 43 pain 28 T12 + conus 
medullaris
partial no yes 60 Same location no
24, F 49 pain + deficit 35 T1–T2 total no no –  – no
25, M 58 pain + deficit 44 c4–c7 total no no –  – no
26, F 12 pain + deficit 6 T3–T6 total yes yes 5 same location  
e craniospinal 
seeding
no
27, F 45 pain 13 T9–T12 total no no –  – no
28, M 19 deficit 5 c3–c7 total no no –  – no
29, F 28 deficit 1 conus 
medullaris
total no no –  – yes
30, M 33 pain + deficit 4 filum 
terminale
total No no –  – no
31, M 36 pain + 
dysesthesias
8 c3–c5 total No no –  – no
M: male; F: female; deficit: motor deficits (tetra– or paraparesis); c: cervical; T: thoracic; l: lumbar; rT: radiation therapy; QT: chemotherapy.
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tween symptoms onset and the surgery was not statisti-
cally significant (p=0.805 and p=0.623, respectively). 
The gross total resection was achieved in 58.8% of 
cases; supratentorial in 83.3% of cases and infratentori-
al in only 31.5% of cases. Follow-up ranged from 1 to 120 
months (mean of 38 months). The 2-year survival was 70%, 
and 5-year survival was 60%, calculated by Kaplan-Meier 
method (Fig 2A). 
Twelve patients with intracranial ependymoma re-
curred; 8 at the primary site, ranging from one to 90 
months after surgery (mean of 21 months). The adjuvant 
therapy with chemotherapy or radiotherapy was indicated 
in 55.9% of the patients either when the tumor had subto-
tal resection or if it recurred. No association was noticed 
between the degree of resection and the tumor location 
with recurrence or survival. Also, there was no statistical-
ly significant correlation between survival and gender or 
patients’ age in cases of intracranial ependymoma. 
The age of patients with intramedullary ependymoma 
ranged from 9 to 63 years (mean of 32 years) (Fig 1B). Fif-
teen patients were female (48.4%). The time between the 
onset of symptoms and surgery ranged from one month 
to 10 years (mean of 31 months). The symptom of neuro-
logical deficit (tetra- or paraparesis) was present in 80.7% 
cases, and associating painful aching sensations with neu-
rological deficit was more common (38.7%). Neurological 
deficit was the only symptom in 19.4% cases; it was asso-
ciated with other sensory symptoms, such as dysesthesias, 
in 22.6% of cases. The symptoms of sensory disturbances 
were only pain and association of pain and dysesthesias in 
12.9% and 6.5%, respectively. The more commonly affect-
ed site was thoracic (29%) and cervical cord (25.8%); only 
in 9.7% of the cases the location was exclusively in the co-
nus medullaris and filum terminale. The lesions were pres-
ent in the cervico-thoracic and thoraco-lumbar transition 
in 19.4% and 16.1% of the population, respectively. No cor-
relation was observed between the location and the clini-
cal presentation with the duration of symptoms until sur-
gery (p=0.362 and p=0.835, respectively). 
Fig 1. Age frequency of the patients with intracranial [A] and in-
tramedullary [B] ependymoma at the time of first surgery.
Fig 2. Overall survival (Kaplan-Meier survival curve) before first sur-
gery until death or the last follow-up in patients with intracranial 
[A] and intramedullary ependymoma.
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The gross total resection was achieved in 77.4% cases 
of intramedullary ependymoma and there was no corre-
lation between the location and the degree of resection 
(p=0.362). The cause of subtotal resection was the lack of 
tumor limits or the linkage between tumor and normal 
tissue. There were no sensory or motor evoked potentials 
(MEP) used throughout the procedure. The tumor grade 
was myxopapillary ependymoma (wHo grade I) in 5 cas-
es in lumbar or thoraco-lumbar location; all other were 
ependymoma (wHo grade II). Follow-up ranged from one 
month to 10 years (mean of 53 months). The 5 and 10-year 
survival was about 90% and 70%, respectively (Fig 2B), ac-
cording to Kaplan-Meier analysis. recurrence occurred in 
seven cases (31.8%), four of them being at the primary site. 
No correlation was identified between the degree of re-
section and recurrence (p=0.124). The time to recurrence 
ranged from 1 to 60 months (mean was 23 months). Adju-
vant therapy was not routinely indicated, even in subto-
tal resection. only three cases had radiation therapy in-
dicated due to dissemination (two cases) and rapid recur-
rence (one case, 3 months after first surgery). The statisti-
cal analysis failed to identify any factor related to recur-
rence or survival.
dIscUssIon
Most reported series of ependymoma are retrospec-
tive and include only a small number of patients. Addi-
tionally, studies have been conducted over several de-
cades, making it difficult to interpret results since classi-
fication and treatment protocols have been modified over 
time. As a consequence, the prognostic factors currently 
accepted are unsatisfactory5. 
The significance of tumor grade is not always accepted, 
probably due to varying definitions of anaplasia6, to dis-
crepancies among pathologists7, and to the fact that histo-
logical features of anaplasia seem to be unrelated to the 
biological behavior of ependymomas8. Another confound-
ing factor is that most series do not distinguish cases with 
malignant ependymoma from those with ependymoblasto-
ma, which have worse prognoses and distinct classification. 
A direct correlation between age and better prognos-
tic was suggested. The small number of cases, the differ-
ent definitions of pediatric age among series (ranging from 
12 to 20 years), and also, the heterogeneity of histological 
grade and tumor location have not allowed to draw defi-
nite conclusions. Ependymomas are rare in adults. Adults 
present better prognosis and the 5-year survival is about 
90%, while in the pediatric population it is around 60%. 
overall, the younger the child the worse the prognoses8. 
However, no correlation was observed between age and 
survival in our series.
The prognostic role of tumor location is also contro-
versial. Intramedullary lesions present more favorable 
prognosis but the intracranial tumors have uncertain 
prognoses. Some authors concluded that there was no 
relationship between prognosis and location, while oth-
ers concluded that supratentorial lesions indicated worse 
prognosis due to their infiltrative characteristics in brain 
parenchyma, hindering total resection9,10. Furthermore, in-
fratentorial tumors present a mitotic activity lower than 
supratentorial tumors11. Some authors observed a worse 
prognosis for ependymoma arising from posterior fossa, 
which occurs in younger patients and generally invades 
the brainstem, the floor of fourth ventricle, the cerebel-
lopontine angle and the cranial nerves, making it diffi-
cult for a complete resection9,11. In this series, no corre-
lation was noticed between the tumor location and the 
prognosis (correlation with recurrence, p=0.814; correla-
tion with death, p=0.147), although it was observed that 
gross total resection was more statistically significant in 
the supratentorial tumors than in the infratentorial ones 
(83.3% × 31.5%; p=0.01).
The degree of resection was considered an indepen-
dent prognostic factor; the complete resection presented 
better 5-year survival than subtotal removal or biopsy12,13. 
In some cases, the benefit of complete resection was lim-
ited to low-grade tumors14. However, some authors failed 
to find a correlation between improved survival and the 
extent of resection15-17. The lack of evidence for the im-
pact of surgery on survival could be related to the unre-
liability of subjective assessment of the degree of surgi-
cal ablation, that is, when the degree of resection is not 
evaluated by postoperative imaging. It was proved that 
the surgeon evaluated the degree of resection in a differ-
ent way than that observed in the postoperative imaging 
in 32% cases18. The degree of resection, assessed by post-
operative imaging, has been related with an improved fol-
low-up in 5-year survival18. In the present series no signifi-
cant correlation was identified between the degree of re-
section and improvement in follow-up, such as longer sur-
vival or lower recurrence of tumors.
The impact of postoperative radiotherapy in the treat-
ment of these patients was not totally supported due to 
the absence of controlled and randomized studies. Al-
though data is lacking, there is consensus that postopera-
tive radiotherapy should integrate the standard treatment 
in the majority of the cases since failure of local control 
of tumor growth is still the most significant factor con-
tributing to recurrence and poor survival. The option to 
follow-up patients until there are symptoms of disease 
progression may be adopted, since late side effects are 
one of the main complications among long-term survi-
vors. craniospinal irradiation should be restricted to pa-
tients with evidence of cranio-spinal seeding. In this se-
ries, postoperative radiotherapy was indicated in subtotal 
resections or recurrence. In three high-grade tumor cases, 
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postoperative radiotherapy was indicated although gross 
total resection was achieved (these cases did not recur).
Intramedullary ependymomas present different prog-
nosis from intracranial tumors. The strongest predictor of 
post-operative functional outcome is pre-operative func-
tional ability. The aim of surgery is to preserve rather than 
restore neurological function. The morbidity and mortal-
ity are directly related with postoperative deficits, while 
postoperative deficits correlate with the pre-operative 
status and the tumor location. The tumor growth is gen-
erally slow; outcome and the risk of recurrence depend 
on the degree of resection in the first surgery4. The post-
operative radiotherapy is unnecessary when the resection 
is complete. when resection is incomplete the need of ra-
diotherapy is difficult to interpret, because studies con-
template small series with limited follow-up usually with 
no control groups19. In this series the radiotherapy was 
indicated only when dissemination was evident and in a 
case which recurrence was premature (three months after 
the first surgery). Significant correlation was not observed 
between the lesion location and survival or the degree of 
resection (p=0.295 and p=0.362, respectively).
In conclusion, the study of ependymomas is of great 
interest. Many studies have been published throughout 
the years; however, handling these patients is still contro-
versial. Surgery alone or combinations of resection with 
chemotherapy and radiotherapy have been proposed as 
forms of treatment. The absence of standard treatment 
and randomized studies hindered the establishment of 
the best treatment strategy20. Although the surgery has a 
well established role, adjuvant treatment procedures are 
still uncertain. 
In the presented series, the degree of resection was 
connected with the intracranial tumor location with statis-
tically significant correlation, although this finding was not 
a predictor for recurrence. The clinical data study of in-
tramedullary ependymoma patients did not allow defining 
characteristics of survival and probability of recurrence. 
It is necessary to understand better the molecular bi-
ology of ependymomas to improve the evaluation of the 
treatment and the outcome of patients.
reFerences
 1. Oppenheim JS, Strauss RC, Mormino J, et al. Ependymomas of the third 
ventricle. Neurosurgery 1994;34:350-352.
 2. Centero RS, Lee AA, Winter J, Barba D. Supratentorial ependymo-
mas. Neuroimaging and clinicopathological correlation. J Neurosurg 
1986;64:209-215.
 3. Biegel JA. Cytogenetics and molecular genetics of childhool brain tu-
mors. NeuroOncol 1999;1:139-151.
 4. Schwartz TH, McCormick PC. Intramedullary ependymomas: clinical 
presentation, surgical treatment strategies and prognosis. J NeuroOn-
col 2000;47:211-218.
 5. Reni M, Gatta G, Mazza E, Vecht C. Ependymoma. Crit Rev Oncol/He-
matol 2007;63:81-89.
 6. Schiffer D, Chio A, Cravioto H, et al. Ependymomas: internal correla-
tions among pathological signs: the anaplastic variant. Neurosurgery 
1991;29:206-210.
 7. Robertson PL, Zelter PM, Boyett JM, et al. Survival and prognostic fac-
tors following radiation therapy and chemotherapy for ependymomas 
in children: a case report of the Children’s Cancer Group. J Neurosurg 
1998;88:695-703.
 8. Schiffer D, Chio A, Giordana MT, et al. Histologic prognostic factors. 
Radiother Oncol 1997;45:3-10.
 9. Vanuytsel LJ, Bessell EM, Ashley SE, et al. Intracranial ependymoma: 
long-term results of a policy of surgery and radiotherapy. Int Radiat 
Oncol Bio Phys 1992;23:313-319.
10. MacLaughlin MP, Marcus Jr Rb, Buatti JM, et al. Ependymoma: results, 
prognostic factors and treatment recommendations. Int J Radiat Oncol 
Biol Phys 1998;40:845-850.
11. Goldwein JW, Leahy JM, Packer RJ, et al. Intracranial ependymomas in 
children. Int J Radiat Oncol Biol Phys 1990;19:1497-1502.
12. Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of intracranial 
ependymomas of children: review of a 15-year experience. Int J Radiat 
Oncol Biol Phys 1994;28:381-386.
13. Sutton LN, Goldwein J, Perilongo G et al. Prognostic factors in child-
hood ependymomas. Pediatr Neurosurg 1990;6:57–65.
14. Nazar GB, Hoffman HJ, Becker LE, et al. Infratentorial ependymomas in 
childhood: prognostic factors and treatment. J Neurosurg 1990;72:408-417.
15. Lyons MK, Kelly PJ. Posterior fossa ependymomas: report of 30 cases 
and review of the literature. Neurosurgery 1991;28:659-664.
16. Pierre-Kahn A, Hirsch JF, Roux FX, et al. Intracranial ependymomas 
in childhood. Survival and functional results of 47 cases. Childs Brain 
1983;10:145-156.
17. Paulino AC, Wen BC. The significance of radiotherapy treatment 
duration in intracranial ependymoma. Int J Radiot Oncol Biol Phys 
2000;47:585-589.
18.	 Healey	EA,	Barnes	PD,	Kupsky	WJ,	et	al.	The	prognostic	significance	of	
postoperative residual tumor in ependymoma. Neurosurgery 1991;28: 
666-671.
19. Wen BC, Hussey DH, Hitchon PW, et al. The role of radiation thera-
py in the management of ependymomas of the spinal cord. Int J Radi-
at Oncol Biol Phys 1991;20: 781-786. 
20. Boufft E, Perilongo G, Canete A, Massimino M. Intracranial ependymo-
mas in children: a critical review of prognostic factors and a plea for co-
operation. Med Pediat Oncol 1998;30:319-331.
